TIMP2 and fibrosarcoma: With a highly potent invasive potential, the fibrosarcoma HT1080 cells exhibit aberrant secretion of MMP-2 and MMP-14, which acts as the receptor of TIMP2; accordingly, this may be the mechanistic basis for selective intense binding of the TIMP2-based protein LT to fibrosarcomas.